EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Peripheral T-cell transitions following proton pump inhibitor therapy in eosinophilic esophagitis

John Plate iD, Christine Lingblom iD, Helen Larsson

Clinical and Experimental Immunology · 2026

DOI: 10.1093/cei/uxag051 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Immunology, 2026. Verfasst von John Plate und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology Head and Neck Surgery, Region Västra Götaland, NU-Hospital Group, Trollhättan, Sweden. Hauptthemen laut MEDLINE: Proton Pump Inhibitors, Eosinophilic Esophagitis, CD8-Positive T-Lymphocytes, T-Lymphocyte Subsets. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fyrbodal Research and Development Council Region Västra Götaland, Konsul Bergh Foundation, Åke Wiberg Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Eosinophilic esophagitis (EoE) is a chronic allergic inflammatory condition characterized by eosinophilic infiltration of the esophagus and dysregulated T-cell responses. Proton pump inhibitors (PPIs) are a treatment option for patients with EoE; however, biomarkers for noninvasive monitoring of treatment response are lacking. In this study, we prospectively enrolled 20 patients with EoE who were treated with PPIs, of whom 19 completed their treatment, and analyzed peripheral blood immune profiles using mass cytometry (CyTOF), comparing them with age- and sex-matched healthy controls. Histologically, 14 of 19 patients achieved histologic remission, whereas immunophenotyping was performed in 17 patients (12 responders and 5 nonresponders) because 2 samples contained insufficient cell numbers. The patients were also evaluated using the EoE Histology Scoring System (EoE-HSS; stage and grade), endoscopic findings, and validated questionnaires. Unsupervised clustering identified key T-cell populations altered by treatment, including Th2 central memory CD4+ T cells and CD8+ terminal effector and naïve subsets. Successful PPI therapy was associated with expansion of FOXP3+ T cells and reduction in cytotoxic CD56+ CD8+ T cells, modulations not detected in nonresponders. Notably, peripheral CD4+ T-cell counts correlated with histologic disease severity (EoE-HSS), whereas eosinophil counts did not. These findings highlight dynamic shifts in circulating T-cell phenotypes following PPI therapy and suggest that expansion of FOXP3+ T-cells and reduction of CD56+ CD8+ T-cell populations may represent candidate treatment-associated immune signatures in EoE. However, given the exploratory nature of this high-dimensional immunophenotyping study and the limited sample size, these findings should be considered hypothesis-generating and require validation in larger independent cohorts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proton Pump InhibitorsEosinophilic EsophagitisCD8-Positive T-LymphocytesT-Lymphocyte SubsetsCD4-Positive T-LymphocytesHumansFemaleMaleAdultMiddle AgedImmunophenotypingProspective StudiesYoung AdultTh2 Cells

Stichwörter der Autor:innen

CyTOFT cellscluster analysiseosinophilic esophagitishumanproton pump inhibitors

Substanzen

Proton Pump Inhibitors

Autor:innen und Institutionen

  • Department of Otorhinolaryngology Head and Neck Surgery, Region Västra Götaland, NU-Hospital Group, Trollhättan, Sweden.
  • Department of Otorhinolaryngology, Head and Neck Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Department of Infectious Diseases, Institute of Biomedicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Department of Clinical Microbiology, Sahlgrenska University Hospital, Gothenburg, Sweden.

ORCID-Profile: John Plate, Christine Lingblom

Förderung

  • Fyrbodal Research and Development Council Region Västra Götaland
  • Konsul Bergh Foundation
  • Åke Wiberg Foundation
  • Asthma and Allergy Association's Research Fund
  • Frenckner Fund for ENT Research
  • Swedish Society of Medicine

Zitieren

APA

Plate, J., Lingblom, C., & Larsson, H. (2026). Peripheral T-cell transitions following proton pump inhibitor therapy in eosinophilic esophagitis. Clinical and Experimental Immunology. https://doi.org/10.1093/cei/uxag051

Vancouver

Plate J, Lingblom C, Larsson H. Peripheral T-cell transitions following proton pump inhibitor therapy in eosinophilic esophagitis. Clinical and Experimental Immunology. 2026. doi:10.1093/cei/uxag051

BibTeX
@article{Plate2026,
  author = {Plate, John and Lingblom, Christine and Larsson, Helen},
  title = {Peripheral T-cell transitions following proton pump inhibitor therapy in eosinophilic esophagitis},
  journal = {Clinical and Experimental Immunology},
  year = {2026},
  doi = {10.1093/cei/uxag051}
}
Kostenlos starten →